AI-assisted, source-referenced information. Independent clinical review is pending. Our standards.
The short answer

A useful price comparison matches the prescribed product and supply period, then separates introductory savings from repeat costs. It also checks the clinical service you can use when treatment needs review.

First make sure the products are comparable

Write the medicine, formulation, strength and quantity beside each price. An injection and a tablet are not equivalent items, and a starter dose is not the same prescription as a maintenance dose. With Wegovy 7.2 mg, the device and number of supplied injections also matter. A low price for one pen may not describe the complete prescribed regimen.

Confirm the intended number of treatment days. Four weekly doses cover 28 days; 30 once-daily tablets cover 30 days when used as prescribed. The label 'monthly' can conceal that difference. Compare the supplied period explicitly instead of assuming that every subscription uses a calendar month.

Sources: Eli Lilly / electronic medicines compendium: Mounjaro KwikPen: patient information leaflet; Novo Nordisk / electronic medicines compendium: Wegovy FlexTouch: UK Summary of Product Characteristics; Eli Lilly / electronic medicines compendium: Foundayo: patient information leaflet; Novo Nordisk / electronic medicines compendium: Wegovy tablets: patient information leaflet

Separate the first payment from the repeat payment

Create two lines for each service: what you would pay for the first eligible order, and what you would pay next time without that introductory offer. Include delivery, assessment, prescription or subscription charges where the service applies them. Check the offer's expiry, eligibility and whether a code can be used on the prescribed strength.

For illustration only, a £150 supply lasting 28 days has a medicine-only cost of about £5.36 per day. A £160 supply lasting 30 days is about £5.33 per day. Those invented figures demonstrate a calculation, not a current offer. Clinical suitability and service quality remain separate from that arithmetic.

Do not assume the starter price lasts

Ask for the repeat price at the current dose and the published prices of doses the clinician might later consider. Treat these as scenarios, not a forecast that you will follow every escalation step. A decision to remain at a dose should come from the treatment review, not from attempting to make a spreadsheet's cheapest path work.

An honest budget includes uncertainty. Leave room for a price change or a prescription review rather than assuming a discount is permanent. If the ongoing cost is not manageable, tell the prescriber before treatment begins or before a gap develops. Affordability is useful clinical context.

Sources: NICE: Prescribing, reviewing and stopping tirzepatide; General Pharmaceutical Council and UK health organisations: How to keep safe when getting medicines or treatment online

Compare the support you can actually reach

Find out who assesses suitability, who issues the prescription and which pharmacy dispenses it. Check the healthcare service and professionals through the relevant official registers. Ask how to contact a clinician between orders, how adverse effects are handled and what happens if your treatment needs to pause.

A lengthy list of extras is less useful than a clear route to care. Ask whether reviews are scheduled or only available on request, whether there is an additional fee, and how a transfer to another provider is documented. Check cancellation and refund terms, including what happens if the clinical assessment does not result in a prescription.

Sources: General Pharmaceutical Council and UK health organisations: How to keep safe when getting medicines or treatment online

A discount never replaces a prescription assessment

The MHRA warns against buying weight-loss medicines without a prescription from unregulated websites or social media sellers. A convincing storefront, an attractive price or a familiar brand image does not establish a legitimate supply. Use the relevant regulator's own record rather than trusting a badge displayed by a seller.

Do not alter a dose, extract leftovers or combine tablets to make an offer cheaper. If the best price requires a different treatment, take that information to the prescriber as a question. The role of a comparison site is to clarify costs and terms after clinical suitability has been considered, not to decide which medicine you should take.

Sources: MHRA: MHRA warns against buying weight loss medicines without a prescription; Eli Lilly / electronic medicines compendium: Mounjaro KwikPen: patient information leaflet; Eli Lilly / electronic medicines compendium: Foundayo: patient information leaflet; Novo Nordisk / electronic medicines compendium: Wegovy tablets: patient information leaflet

Questions, answered.

Is the lowest first-order price always the cheapest course?

No. Repeat prices, supply duration, dose changes and additional charges can change the total. Compare the same prescribed supply and show assumptions openly.

Can a comparison guarantee the price at checkout?

No. Check the provider's current price, stock, offer conditions and clinical eligibility before relying on a quote. A dated observation is a snapshot.

Sources & further reading

Original sources for this guide. Source checks are not independent clinical review.

  1. Mounjaro KwikPen: patient information leafletEli Lilly / electronic medicines compendium · Accessed 19 November 2026
  2. Wegovy FlexTouch: UK Summary of Product CharacteristicsNovo Nordisk / electronic medicines compendium · Accessed 19 November 2026
  3. Foundayo: patient information leafletEli Lilly / electronic medicines compendium · Accessed 19 November 2026
  4. Wegovy tablets: patient information leafletNovo Nordisk / electronic medicines compendium · Accessed 19 November 2026
  5. Prescribing, reviewing and stopping tirzepatideNICE · Accessed 19 November 2026
  6. How to keep safe when getting medicines or treatment onlineGeneral Pharmaceutical Council and UK health organisations · Accessed 19 November 2026
  7. MHRA warns against buying weight loss medicines without a prescriptionMHRA · Accessed 19 November 2026